The pharmaceutical sector of 2022 is under more pressure than it has faced in living memory. In addition to the ongoing effects of Covid, increased regulation and spiraling business costs, the issue of fake medicines continues to cause serious concerns
It is predicted that 10% of pharma products worldwide are counterfeit, with the global counterfeit drug market exceeding an eye-watering $75bn. Research further estimates that the death-toll caused as a...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?